FCE
IPXL

Fiera Capital (Europe)’s Impax Laboratories, Inc. IPXL Stock Holding History

Fiera Capital (Europe)’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-8,500
Closed -$244K – 47
2016
Q2 		$244K Buy
8,500
+2,546
+43% +$83K 0.19% 29
2016
Q1 		$191K Buy
5,954
+2,005
+51% +$70.5K 0.19% 32
2015
Q4 		$170K Hold
3,949
– – 0.2% 38
2015
Q3 		$139K Hold
3,949
– – 0.18% 39
2015
Q2 		$181K Hold
3,949
– – 0.16% 35
2015
Q1 		$185K Buy
3,949
+2,523
+177% +$100K 0.17% 35
2014
Q4 		$104 Sell
1,426
-1,439
-50% -$42.1K 0.08% 42
2014
Q3 		$68K Hold
2,865
– – 0.05% 50
2014
Q2 		$86K Buy
+2,865
New +$77.3K 0.07% 41

Other funds holding IPXL

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fiera Capital (Europe)'s IPXL Position: Q3 2016 in Review

Fiera Capital (Europe) sold out of Impax Laboratories, Inc. (IPXL) in Q3 2016, closing a stake of 8,500 shares — an estimated $244K sold.

Fiera Capital (Europe) first reported a position in IPXL in Q2 2014 and held it in 9 quarters. The position peaked at $244K in Q2 2016. 196 funds tracked by Wall St. Rank hold IPXL as of Q3 2016.

  • Fiera Capital (Europe) reported no remaining Impax Laboratories, Inc. position as of Q3 2016 after selling out during the quarter.
  • Fiera Capital (Europe) sold 8,500 Impax Laboratories, Inc. shares in Q3 2016, an estimated $244K.
  • Fiera Capital (Europe) first reported a position in Impax Laboratories, Inc. in Q2 2014 and held it in 9 quarters.
  • Fiera Capital (Europe)'s Impax Laboratories, Inc. position peaked at $244K in Q2 2016.
  • 196 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q3 2016.

Based on Fiera Capital (Europe)'s 13F filing for Q3 2016, filed 10 Nov 2016.